Good News | Congratulations on the market approval of Fulvestrant Injection of Hangzhou Jiuyuan assisted by Yeedo
On June 28, 2022, Yeedo, as the registered partner of Hangzhou Jiuyuan, successfully helped Jiuyuan obtain the marketing approval of "Fluvestrant Injection"( a category 4 drug)!
In 2002, the FDA approved AstraZeneca's (formerly Zeneca) Fulvestrant for the first time for locally advanced or metastatic breast cancer with estrogen receptor-positive postmenopausal (both natural and artificial) breast cancer that recurs after or during antiestrogen adjuvant therapy or progresses during antiestrogen therapy. This product has been included in the first batch of encouraged generic drug catalog. At present, Hangzhou Jiuyuan's Flulvestrant injection has been approved for marketing, and its industrialization will bring benefits to the treatment of advanced/metastatic breast cancer patients.
About Hangzhou Jiuyuan
About Hangzhou Jiuyuan
Hangzhou Jiuyuan Genetic Engineering Co., Ltd. is a modern biopharmaceutical enterprise specializing in the research and development, production and sales of genetic engineering drugs, biochemical drugs, and medical devices. Founded in December 1993, as a member of Huadong Medicine, the company is one of the earliest genetic engineering pharmaceutical enterprises in Zhejiang province and even in China.
About Yeedo
Yeedo is a full life cycle management service provider for drug R&D with both depth and humanity. On the basis of in-depth scientific knowledge and profound professional grasp of customer products, the company is committed to providing appropriate solutions with characteristics; as we can understand the difficulties of r&d, production, circulation and use in full life cycle with Chinese characteristics from the customer's perspective, the company is full of warm care in the implementation of depth-based solutions. After years of accumulation, the company has established and improved the integrated service platform integrating project operation management, clinical research, registration services, biological sample analysis, data management and statistics, aiming to help pharmaceutical enterprises shorten the time of R&D, provide value-added technical services, and bring products to the market as soon as possible.
website：www.china-gene.com
email：office@china-gene.com
Yeedo is a full life cycle management service provider for drug R&D with both depth and humanity. On the basis of in-depth scientific knowledge and profound professional grasp of customer products, the company is committed to providing appropriate solutions with characteristics; as we can understand the difficulties of r&d, production, circulation and use in full life cycle with Chinese characteristics from the customer's perspective, the company is full of warm care in the implementation of depth-based solutions. After years of accumulation, the company has established and improved the integrated service platform integrating project operation management, clinical research, registration services, biological sample analysis, data management and statistics, aiming to help pharmaceutical enterprises shorten the time of R&D, provide value-added technical services, and bring products to the market as soon as possible.
